Beneficient

NEW YORK, Oct. 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public.

New York, New York--(Newsfile Corp. - October 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - October 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Beneficient (NASDAQ: BENF) resulting from allegations that Beneficient may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Beneficient securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.